Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8101 USD | -3.56% | -1.81% | +42.12% |
05-14 | Viracta Therapeutics Appoints Michael Faerm CFO | MT |
05-14 | Viracta Therapeutics, Inc. Appoints Michael Faerm as Chief Financial Officer | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.12% | 31.81M | |
+33.37% | 50.85B | |
+1.55% | 42.82B | |
+49.28% | 42.03B | |
-4.22% | 29.55B | |
+11.57% | 26.11B | |
-21.00% | 19.13B | |
+7.36% | 13.05B | |
+28.30% | 12.16B | |
+23.80% | 12.08B |
- Stock Market
- Equities
- VIRX Stock
- News Viracta Therapeutics, Inc.
- Viracta Therapeutics to Expand Cohort of Patients in Virus-Associated Cancers Clinical Trial